ReviewCancer medicine2026

Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers.

Mobina Darabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.